Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/5730
Title: | To Evaluation of Effectiveness of Chelatory Therapy in Patients with Talassemia |
Authors: | Zaynutdinova D.L., Qudratova M.F., Qo’ziyeva M.G., Muhammadaminova D.R., Axtamov A.J. |
Keywords: | anemia, hemoglobinopathy, thalassemia, hemosiderosis |
Issue Date: | 2022 |
Publisher: | USA |
Series/Report no.: | УДК; |
Abstract: | The term “thalassemia” refers to a group of autosomal-recessive blood diseases charaeterized by a decrease in the synthesis of one of two types of polypeptide chains of globin (α or β), that form a molecule of adult hemoglobin(HbA, α2β2). This leads to a decrease in the filling of erythrocytes with hemoglobin and anemia. In Uzbekistan, the birth rate with this disease is 10-15 per year. At present in the Republic of Uzbekistan, 184 patients with thalassemia are registered at the Research Institute of Hematology and Blood Transfuzion at the Dispensary |
URI: | http://repository.tma.uz/xmlui/handle/1/5730 |
Appears in Collections: | Thesis, Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Zaynutdinova D.L. O'zbek.pdf | To Evaluation of Effectiveness of Chelatory Therapy in Patients with Talassemia | 449.15 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.